New Prostate Cancer Screening Guidelines Don't Go Far Enough (Op-Ed)

New Prostate Cancer Screening Guidelines Don't Go Far Enough (Op-Ed)
"Dr. David Samadi is the chairman of urology and chief of robotic surgery at Lenox Hill Hospital in New York City and is a board-certified urologist and oncologist specializing in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer and prostate cancer. 
He contributed this article to Live Science's Expert Voices: Op-Ed & Insights.

"A disturbing trend has been emerging in my practice over recent years: More men are being diagnosed with aggressive prostate cancer, and in some cases the cancer has already metastasized to the bones and become incurable. 
It's a direct result, in my opinion, of 2012 guidelines by an influential government panel recommending against routine prostate cancer screening in men of all ages.
...Prostate cancer is the most common cancer in American men after skin cancer, affecting 1 in 7 males, according to the American Cancer Society (ACS). 
More than 161,000 men are expected to be diagnosed with the disease this year and nearly 27,000 will die, according to the ACS. 
By the numbers, prostate cancer and breast cancer..."